1-20 of 31
warfarin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions

Sara R. Vazquez
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 339–347.
https://doi.org/10.1182/asheducation-2018.1.339
Published: 2018
Journal Articles

Optimizing quality care for the oral vitamin K antagonists (VKAs)

Vittorio Pengo, Gentian Denas
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 332–338.
https://doi.org/10.1182/asheducation-2018.1.332
Published: 2018
Journal Articles

Role of the anticoagulant monitoring service in 2018: beyond warfarin

Nathan P. Clark
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 348–352.
https://doi.org/10.1182/asheducation-2018.1.348
Published: 2018
Journal Articles

Safety profiles of novel agent therapies in CLL

Inhye E. Ahn, Matthew S. Davids
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 354–357.
https://doi.org/10.1182/asheducation-2017.1.354
Published: 2017
Journal Articles

Plasma versus prothrombin complex concentrate for warfarin-associated major bleeding: a systematic review

Deborah M. Siegal, William J. Savage
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 448–453.
https://doi.org/10.1182/asheducation-2015.1.448
Published: 2015
Journal Articles

Anticoagulants in children and adolescents

Guy Young
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 111–116.
https://doi.org/10.1182/asheducation-2015.1.111
Published: 2015
Journal Articles

Bleeding complications of targeted oral anticoagulants: what is the risk?

Michael Levine, Joshua N. Goldstein
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 504–509.
https://doi.org/10.1182/asheducation-2014.1.504
Published: 2014
Journal Articles

Reversing targeted oral anticoagulants

Maureane Hoffman, Dougald M. Monroe
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 518–523.
https://doi.org/10.1182/asheducation-2014.1.518
Published: 2014
Journal Articles

The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders

Margaret V. Ragni
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 44–51.
https://doi.org/10.1182/asheducation-2013.1.44
Published: 2013
Journal Articles

Pros and cons of new oral anticoagulants

Kenneth A. Bauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 464–470.
https://doi.org/10.1182/asheducation-2013.1.464
Published: 2013
Journal Articles

Is there a role for warfarin anymore?

Alan Jacobson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 541–546.
https://doi.org/10.1182/asheducation.V2012.1.541.3798556
Published: 2012
Journal Articles

Antithrombotic therapy: triple therapy or triple threat?

Jessica Mega, Edward T. Carreras
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 547–552.
https://doi.org/10.1182/asheducation.V2012.1.547.3798919
Published: 2012
Journal Articles

Perioperative management of patients on chronic antithrombotic therapy

Thomas L. Ortel
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 529–535.
https://doi.org/10.1182/asheducation.V2012.1.529.3799663
Published: 2012
Journal Articles

New oral anticoagulants: which one should my patient use?

Jeffrey I. Weitz, Peter L. Gross
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 536–540.
https://doi.org/10.1182/asheducation.V2012.1.536.3798545
Published: 2012
Journal Articles

Thrombosis in Multiple Myeloma

Sigurdur Yngvi Kristinsson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 437–444.
https://doi.org/10.1182/asheducation-2010.1.437
Published: 2010
Journal Articles

Warfarin Versus New Agents: Interpreting the Data

Jack Ansell
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 221–228.
https://doi.org/10.1182/asheducation-2010.1.221
Published: 2010
Journal Articles

Antiphospholipid antibody syndrome

Wendy Lim
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 233–239.
https://doi.org/10.1182/asheducation-2009.1.233
Published: 2009
Journal Articles

Warfarin: An Historical Perspective

Charles W. Francis
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 251.
https://doi.org/10.1182/asheducation-2008.1.251
Published: 2008
Journal Articles

New Issues in Oral Anticoagulants

Charles W. Francis
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 259–265.
https://doi.org/10.1182/asheducation-2008.1.259
Published: 2008
Journal Articles

What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin?

Rachel P. Rosovsky, Mark A. Crowther
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 36–38.
https://doi.org/10.1182/asheducation-2008.1.36
Published: 2008